DNA Company 23andMe Gets FDA Approval for Consumer Cancer Test

(Bloomberg) -- DNA testing company 23andMe Inc. said it has gotten the green light from the U.S. Food and Drug Administration to offer consumers a test for a hereditary colorectal cancer syndrome.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.